Industry Update: Eli Lilly to Acquire Orna Therapeutics to Advance Cell Therapies

Industry Update: Providence Therapeutics Commences mRNA PCV Trial in Australia for Brain Cancers

Industry Update: CREATE Medicines Demonstrates B-Cell Depletion & Repeatable Dosing with In Vivo CAR-T

Industry Update: NeuCyte & Grann Pharma Enter Partnership for mRNA-Based Therapies for Rare Neurological Diseases

Industry Update: Adjuva Bio Awarded CELLSCRIPT™ 2026 mRNA Research Grant to Enhance Next-Gen In Vivo Cell Therapies